2 Dependable Dividend Stocks That Can Pay You for Life
What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how juicy its dividend yield. For those seeking dividend stocks to buy and hold for good, it's best to opt for companies that have proven they can perform relatively well -- and continue raising their dividends -- through economic and market fluctuations.Medtronic (NYSE: MDT) and Abbott Laboratories (NYSE: ABT) are two such examples in the healthcare industry. Both are leading medical device giants that should continue paying dividends for a long time. Let me explain.Medtronic's business spans several therapeutic areas where it develops and markets medical devices for areas including diabetes care, neuroscience, cardiovascular health, and medical-surgical. The company boasts dozens of products and routinely earns clearance for new ones or more indications for existing ones. Medtronic bagged about 120 approvals in the past 12 months alone.Continue reading
What makes an outstanding dividend stock? High yields can seem attractive to income seekers, but unless a company has a steady, reliable business, payout cuts are a real possibility no matter how juicy its dividend yield. For those seeking dividend stocks to buy and hold for good, it's best to opt for companies that have proven they can perform relatively well -- and continue raising their dividends -- through economic and market fluctuations.
Medtronic (NYSE: MDT) and Abbott Laboratories (NYSE: ABT) are two such examples in the healthcare industry. Both are leading medical device giants that should continue paying dividends for a long time. Let me explain.
Medtronic's business spans several therapeutic areas where it develops and markets medical devices for areas including diabetes care, neuroscience, cardiovascular health, and medical-surgical. The company boasts dozens of products and routinely earns clearance for new ones or more indications for existing ones. Medtronic bagged about 120 approvals in the past 12 months alone.
